Article
HIV rapid testing as a key strategy for prevention of mother-to-child transmission in Brazil
Teste rápido para o HIV como estratégia de prevenção da transmissão vertical no Brasil
Registro en:
Veloso, Valdiléa G. et al. HIV rapid testing as a key strategy for prevention of mother-to-child transmission in Brazil. Rev Saúde Pública, v.44, n.5, p.803-11, 2010.
0034-8910
1518-8787
Autor
Veloso, Valdiléa G.
Bastos, Francisco Inácio Pinkusfeld Monteiro
Portela, Margareth Crisóstomo
Grinsztejn, Beatriz
João, Esau Custodio
Pilotto, Jose Henrique da Silva
Araújo, Ana Beatriz Busch
Santos, Breno Riegel
Fonseca, Rosana Campos da
Kreitchmann, Regis
Derrico, Monica
Friedman, Ruth Khalili
Morgado, Mariza Gonçalves
Saines, Karin Nielsen
Bryson, Yvonne J.
Resumen
OBJECTIVE: To assess the feasibility of HIV rapid testing for pregnant women
at maternity hospital admission and of subsequent interventions to reduce
perinatal HIV transmission.
METHODS: Study based on a convenience sample of women unaware of
their HIV serostatus when they were admitted to delivery in public maternity
hospitals in Rio de Janeiro and Porto Alegre, Brazil, between March 2000 and
April 2002. Women were counseled and tested using the Determine HIV1/2
Rapid Test. HIV infection was confi rmed using the Brazilian algorithm for HIV
infection diagnosis. In utero transmission of HIV was determined using HIVDNA-
PCR. There were performed descriptive analyses of sociodemographic
data, number of previous pregnancies and abortions, number of prenatal care
visits, timing of HIV testing, HIV rapid test result, neonatal and mother-tochild
transmission interventions, by city studied.
RESULTS: HIV prevalence in women was 6.5% (N=1,439) in Porto Alegre
and 1.3% (N=3.778) in Rio de Janeiro. In Porto Alegre most of women were
tested during labor (88.7%), while in Rio de Janeiro most were tested in the
postpartum (67.5%). One hundred and forty-four infants were born to 143 HIVinfected
women. All newborns but one in each city received at least prophylaxis
with oral zidovudine. It was possible to completely avoid newborn exposure
to breast milk in 96.8% and 51.1% of the cases in Porto Alegre and Rio de
Janeiro, respectively. Injectable intravenous zidovudine was administered
during labor to 68.8% and 27.7% newborns in Porto Alegre and Rio de Janeiro,
respectively. Among those from whom blood samples were collected within
48 hours of birth, in utero transmission of HIV was confi rmed in 4 cases in
Rio de Janeiro (4/47) and 6 cases in Porto Alegre (6/79).
CONCLUSIONS: The strategy proved feasible in maternity hospitals in Rio
de Janeiro and Porto Alegre. Efforts must be taken to maximize HIV testing
during labor. There is a need of strong social support to provide this population
access to health care services after hospital discharge.